American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.
Last trade$11.19
Day change-$0.15 (-1.32%)
Day range$11.14 – $11.50
Volume37,789
Market cap$195M
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$195.28M
Price / earnings
—
Price / book
0.92×
Price / sales
0.92×
EV / sales
0.07×
EV / EBITDA
-0.41×
Profitability
Earnings per share
-$3.32
Return on assets
-18.46%
Return on equity
-26.97%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.01×
Quick ratio
3×
Cash ratio
2.19×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$19.32M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for AMWL, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$48.99M
$52.05M
$54.88M
$55.31M
$56.29M
$70.9M
$66.83M
$71.01M
Cost of revenue
$23.03M
$24.49M
$26.92M
$26.97M
$26.78M
$31.14M
$31.57M
$36.61M
Gross profit
$25.96M
$27.56M
$27.96M
$28.34M
$29.51M
$39.76M
$35.26M
$34.39M
Selling, general and administrative
$22.78M
$19.75M
$25.45M
$31.06M
$30.81M
$33.67M
$35.77M
$50.16M
Research and development
$9.6M
$10.35M
$12.38M
$13.94M
$18.58M
$18.24M
$22.1M
$18.78M
Total operating expenses
$37.61M
$37.12M
$45.39M
$53.49M
$58.84M
$60.13M
$65.67M
$77.15M
Operating income
-$11.65M
-$9.56M
-$17.42M
-$25.15M
-$29.33M
-$20.38M
-$30.41M
-$42.76M
Interest expense
$1.47M
-$617K
$313K
$0
$638K
$845K
$2.69M
$0
Income before taxes
-$10.19M
-$10.17M
-$17.11M
-$34.23M
-$28.69M
-$19.53M
-$27.72M
-$42.33M
Income taxes
$769K
-$548K
$217K
-$626K
$1.22M
-$725K
$568K
$1.53M
Net income
-$10.96M
-$9.63M
-$10.3M
-$25.17M
-$31.91M
-$19.53M
-$18.36M
-$44.57M
Net income attributable to common shareholders
-$11.36M
-$9.93M
-$10.89M
-$24.92M
-$32.38M
-$19.7M
-$18.7M
-$42.65M
EBITDA
-$6.42M
-$2.54M
-$9.83M
-$16.66M
-$19.89M
-$12.16M
-$22.61M
-$34.55M
Basic earnings per share
-$0.67
-$0.59
-$0.66
-$1.52
-$2.00
-$1.24
-$1.19
-$2.77
Diluted earnings per share
-$0.67
-$0.59
-$0.66
-$1.52
-$2.00
-$1.24
-$1.19
-$2.77
Recent news
Company coverage with links to the original publishers.
American Well (AMWL) stock has declined 8% over the past two weeks but formed a hammer chart pattern in its last trading session, suggesting potential support and trend reversal. The bullish technical signal is reinforced by rising analyst optimism, with consensus EPS estimates for the current year increasing 3.9% over the last 30 days. AMWL holds a Zacks Rank #2 (Buy) rating, placing it in the top 20% of stocks and indicating improving company prospects.
American Well Corporation (AMWL) is highlighted as a stock combining fast-paced momentum with attractive valuation. The stock has gained 1% over 12 weeks with a beta of 1.72, indicating high volatility. It holds a Momentum Score of A and Zacks Rank #2 (Buy), supported by upward earnings estimate revisions. Trading at 0.98 times sales, AMWL appears undervalued despite its momentum characteristics.
American Well Corporation reported a Q3 loss of $0.67 per share, slightly worse than the consensus estimate of $0.66 loss, but revenues of $48.99 million exceeded estimates by 4.10%. The company has outperformed the S&P 500 by 155% year-to-date. Despite mixed estimate revisions, AMWL received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.
Inspire Medical Systems beat Q3 earnings expectations with $0.14 EPS versus consensus of $0.10, and revenues of $206.7M slightly above estimates. However, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends ahead of the earnings release. The stock has underperformed the S&P 500 by 37% year-to-date, and near-term underperformance is expected despite the positive earnings surprise.
American Well (AMWL) shares jumped 6.1% to $14.98 on investor optimism ahead of Q3 2026 earnings expected November 3. The company is projected to report a quarterly loss of $0.66 per share (62.1% improvement year-over-year) with revenues of $47.06 million (down 16.4%). However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock may struggle to sustain momentum without positive estimate trends. AMWL carries a Zacks Rank #3 (Hold).
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.